<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04639323</url>
  </required_header>
  <id_info>
    <org_study_id>CHESS2005</org_study_id>
    <nct_id>NCT04639323</nct_id>
  </id_info>
  <brief_title>Endoscopic Ruler for the Assessment of Variceal Bleeding Risks (CHESS2005)</brief_title>
  <official_title>Endoscopic Ruler for the Assessment of Variceal Bleeding Risks in Portal Hypertension (CHESS2005): A Prospective Multicenter Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hepatopancreatobiliary Surgery Institute of Gansu Province</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>LanZhou University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tianjin Second People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital with Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>People's Hospital of Ningxia Hui Autonomous Region</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Second Affiliated Hospital of Baotou Medical College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Third Xiangya Hospital of Central South University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Second Hospital of Hebei Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Affiliated Hospital Of Southwest Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Hospital of China Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hepatopancreatobiliary Surgery Institute of Gansu Province</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The presence of varices is a serious complication of portal hypertension in liver disease. To&#xD;
      prevent variceal haemorrhage, screening and surveillance aims to detect high-risk varices&#xD;
      related to varices size and determine the need for primary prophylaxis. Varices size&#xD;
      evaluated by endoscopists might not be perfect reference, influenced by experience and&#xD;
      machine. Endoscopic ruler is a novel tool to measure the varices size under the endoscopy.&#xD;
      The investigators aim to evaluate the bias of varices size between endoscopists and&#xD;
      endoscopic ruler as the reference.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 23, 2020</start_date>
  <completion_date type="Anticipated">November 13, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 13, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>7 Days</target_duration>
  <primary_outcome>
    <measure>The intraclass correlation coefficient (ICC) of the varix size and the kappa value of the varices bleeding risk between endoscopists and endoscopic ruler</measure>
    <time_frame>2020/11/13-2022/11/13</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The ICC value of the varix size and the kappa value of the varices bleeding risk among endoscopists</measure>
    <time_frame>2020/11/13-2022/11/13</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The bleeding rate of endoscopic ruler</measure>
    <time_frame>2020/11/13-2022/11/13</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The timing of endoscopic ruler</measure>
    <time_frame>2020/11/13-2022/11/13</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The correlation coefficient between varices size and hepatic venous pressure gradient</measure>
    <time_frame>2020/11/13-2022/11/13</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The correlation coefficient between varices size and decompensated events</measure>
    <time_frame>2020/11/13-2022/11/13</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">266</enrollment>
  <condition>Liver Cirrhosis</condition>
  <condition>Portal Hypertension</condition>
  <condition>Gastroesophageal Varices</condition>
  <arm_group>
    <arm_group_label>Overall eligible participants</arm_group_label>
    <description>Eligible participants whose varix size will be measured by endoscopists and endoscopic ruler will receive standard esophagogastroduodenoscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Endoscopic ruler</intervention_name>
    <description>Endoscopic ruler for varices in portal hypertension&#xD;
Product uses: measuring the diameter of the veins under the endoscopy for the assessment of the risk of variceal haemorrhage in patients with portal hypertension&#xD;
Black and white measuring rule is highly recognizable under the endoscopy&#xD;
The width of each cell is 1 mm, and the measuring range is 0-10 mm&#xD;
With smooth edge, safe and reliable</description>
    <arm_group_label>Overall eligible participants</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The investigators prospectively recruit well-defined participants with liver cirrhosis from&#xD;
        university hospitals. Esophagogastroduodenoscopy is performed by a dedicated endoscopist at&#xD;
        each center. Varices size is evaluated by the endoscopist and endoscopic ruler.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age between 18 and 75 years&#xD;
&#xD;
          -  clinically evident or biopsy-confirmed cirrhosis&#xD;
&#xD;
          -  Varices diagnosed by endoscopy&#xD;
&#xD;
          -  written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  red sign&#xD;
&#xD;
          -  Active upper gastrointestinal bleeding&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiaolong Qi, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>LanZhou University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fengmei Wang, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tianjin Second People's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Guoxin Zhang, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The First Affiliated Hospital with Nanjing Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shengjuan Hu, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>People's Hospital of Ningxia Hui Autonomous Region</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xianmei Meng, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Second Affiliated Hospital of Baotou Medical College</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xiaoyan Wang, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Third Xiangya Hospital of Central South University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zhijie Feng, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Second Hospital of Hebei Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Muhan Lv, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Affiliated Hospital Of Southwest Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yiling Li, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Hospital of China Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xiaolong Qi, M.D.</last_name>
    <phone>+86 18588602600</phone>
    <email>qixiaolong@vip.163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yifei Huang, M.D.</last_name>
    <phone>+86 15800004518</phone>
    <email>huangyf1995@foxmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Second Affiliated Hospital of Baotou Medical College</name>
      <address>
        <city>Baotou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xianmei Meng, M.D.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Third Xiangya Hospital of Central South University</name>
      <address>
        <city>Changsha</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xiaoyan Wang, M.D.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The first hospital of Lanzhou university</name>
      <address>
        <city>Lanzhou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xiaolong Qi, M.D.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital with Nanjing Medical University</name>
      <address>
        <city>Nanjing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Guoxin Zhang, M.D.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Second Hospital of Hebei Medical University</name>
      <address>
        <city>Shijiazhuang</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zhijie Feng, M.D.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tianjin Second People's Hospital</name>
      <address>
        <city>Tianjin</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fengmei Wang, M.D.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>People's Hospital of Ningxia Hui Autonomous Region</name>
      <address>
        <city>Yinchuan</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shengjuan Hu, M.D.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Qi X, Berzigotti A, Cardenas A, Sarin SK. Emerging non-invasive approaches for diagnosis and monitoring of portal hypertension. Lancet Gastroenterol Hepatol. 2018 Oct;3(10):708-719. doi: 10.1016/S2468-1253(18)30232-2. Review.</citation>
    <PMID>30215362</PMID>
  </reference>
  <reference>
    <citation>Cremers I, Ribeiro S. Management of variceal and nonvariceal upper gastrointestinal bleeding in patients with cirrhosis. Therap Adv Gastroenterol. 2014 Sep;7(5):206-16. doi: 10.1177/1756283X14538688. Review.</citation>
    <PMID>25177367</PMID>
  </reference>
  <reference>
    <citation>Bendtsen F, Skovgaard LT, Sørensen TI, Matzen P. Agreement among multiple observers on endoscopic diagnosis of esophageal varices before bleeding. Hepatology. 1990 Mar;11(3):341-7.</citation>
    <PMID>2312048</PMID>
  </reference>
  <reference>
    <citation>Cales P, Pascal JP. Gastroesophageal endoscopic features in cirrhosis: comparison of intracenter and intercenter observer variability. Gastroenterology. 1990 Oct;99(4):1189.</citation>
    <PMID>2203663</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>November 15, 2020</study_first_submitted>
  <study_first_submitted_qc>November 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 20, 2020</study_first_posted>
  <last_update_submitted>August 16, 2021</last_update_submitted>
  <last_update_submitted_qc>August 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hepatopancreatobiliary Surgery Institute of Gansu Province</investigator_affiliation>
    <investigator_full_name>Xiaolong Qi</investigator_full_name>
    <investigator_title>Director, Institute of Portal Hypertension</investigator_title>
  </responsible_party>
  <keyword>Esophagogastroduodenoscopy</keyword>
  <keyword>Endoscopic ruler</keyword>
  <keyword>Varices size</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Hypertension, Portal</mesh_term>
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

